Publicacións (17) Publicacións de JOSE LUIS LABANDEIRA GARCIA Ver datos de investigación referenciados.

filter_list Cellular and Molecular Neuroscience

2021

  1. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

2018

  1. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

    Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081

  2. Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4763-4776

2015

  1. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation

    GLIA, Vol. 63, Núm. 3, pp. 466-482

  2. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinsons Disease

    Neuroscientist, Vol. 21, Núm. 6, pp. 616-629

2014

  1. Brain renin-angiotensin system and dopaminergic cell vulnerability

    Frontiers in Neuroanatomy, Vol. 8, Núm. JULY

  2. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death

    Neuropharmacology, Vol. 85, pp. 1-8

  3. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin

    GLIA, Vol. 62, Núm. 1, pp. 145-157

2012

  1. Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors

    Neurobiology of Disease, Vol. 47, Núm. 2, pp. 268-279

2011

  1. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 97-104

2010

  1. Location of prorenin receptors in primate substantia nigra: Effects on dopaminergic cell death

    Journal of Neuropathology and Experimental Neurology, Vol. 69, Núm. 11, pp. 1130-1142

2009

  1. Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: Potential effects in a 6-OHDA-induced model of Parkinson's disease

    Journal of Neurochemistry, Vol. 109, Núm. 3, pp. 879-888

  2. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: Relevance to progression of the disease

    Journal of Neurochemistry, Vol. 109, Núm. 2, pp. 656-669

2008

  1. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS

    Neurobiology of Disease, Vol. 31, Núm. 1, pp. 58-73

2007

  1. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro

    Developmental Neurobiology, Vol. 67, Núm. 12, pp. 1549-1559

  2. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry, Vol. 103, Núm. 1, pp. 145-156

2003

  1. Host brain regulation of dopaminergic grafts function: Role of the serotonergic and noradrenergic systems in amphetamine-induced responses

    Synapse, Vol. 47, Núm. 1, pp. 66-76